PUBLIC CONTRACT · 2012

Medicamentos Vários em CPA

Contract value: €140,041.13
Signed on: 26 November 2012
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 722751

PUBLISHED SUBJECT

Aquisição de Medicamentos Vários em CPA

WHO CONTRACTED

Parties involved

Contracting body: Hospital do Espírito Santo de Évora, E.P.E.
Awardee: UNILFARMA; JANSSEN CILAG FARMACEUTICA LDA; TEVA PHARMA - PRODUTOS FARMACEUTICOS LDA; BRISTOL-MYERS SQUIB FARMAC PORTUGUESA SA; MERCK SHARP & DOME LDA; FRESENIUS KABI PHARMA PORTUGAL; UCB-PROD FARMACEUTICOS LDA; SANOFI- PRODUTOS FARMACEUTICOS LDA; PHARMIS BIOFARMACEUTICA; BAXTER MEDICO FARMACEUTICA LDA; GLAXOSMITHKLINE-PROD FARMAC LD; RES MEDICAL; IPSEN PORTUGAL; DNA PHARMA LDA; ASTRAZENECA PROD FARM LDA; MERCK SA; GENERIS - FARMACEUTICA SA; LAB PFIZER LDA; CICLUM FARMA UNIPESSOAL LDA; ROCHE FARMACEUTICA QUIMICA LDA; OVERPHARMA LDA; LABESFAL SA; CPH PHARMA SA; AMGEN BIOFARMACEUTICA LDA; SANOFI PASTEUR MSD; LILLY PORTUGAL - PRODUTOS FARMAEUTICOS LDA; B BRAUN MEDICAL LDA; MEDAC; FARMOZ - SOC TECNICO MEDICINAL SA; NOVARTIS FARMA-PROD FARMACEUT; BAYER PORTUGAL S A; MEDA PHARMA S A
Place of performance: Portugal, Évora, Évora
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: UNILFARMA · Tax ID 500293023
Awardee: JANSSEN CILAG FARMACEUTICA LDA · Tax ID 500189412
Awardee: TEVA PHARMA - PRODUTOS FARMACEUTICOS LDA · Tax ID 507045491
Awardee: BRISTOL-MYERS SQUIB FARMAC PORTUGUESA SA · Tax ID 500048193
Awardee: MERCK SHARP & DOME LDA · Tax ID 500191360
Awardee: FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753
Awardee: UCB-PROD FARMACEUTICOS LDA · Tax ID 500291322
Awardee: SANOFI- PRODUTOS FARMACEUTICOS LDA · Tax ID 500134960
Awardee: PHARMIS BIOFARMACEUTICA · Tax ID 502595442
Awardee: BAXTER MEDICO FARMACEUTICA LDA · Tax ID 503347345
Awardee: GLAXOSMITHKLINE-PROD FARMAC LD · Tax ID 500139962
Awardee: RES MEDICAL · Tax ID 502440163
Awardee: IPSEN PORTUGAL · Tax ID 502609800
Awardee: DNA PHARMA LDA · Tax ID 508917654
Awardee: ASTRAZENECA PROD FARM LDA · Tax ID 502942240
Awardee: MERCK SA · Tax ID 500650870
Awardee: GENERIS - FARMACEUTICA SA · Tax ID 508107997
Awardee: LAB PFIZER LDA · Tax ID 500162166
Awardee: CICLUM FARMA UNIPESSOAL LDA · Tax ID 504362674
Awardee: ROCHE FARMACEUTICA QUIMICA LDA · Tax ID 500233810
Awardee: OVERPHARMA LDA · Tax ID 505792362
Awardee: LABESFAL SA · Tax ID 501169580
Awardee: CPH PHARMA SA · Tax ID 500069190
Awardee: AMGEN BIOFARMACEUTICA LDA · Tax ID 502942959
Awardee: SANOFI PASTEUR MSD · Tax ID 507632796
Awardee: LILLY PORTUGAL - PRODUTOS FARMAEUTICOS LDA · Tax ID 500165602
Awardee: B BRAUN MEDICAL LDA · Tax ID 501506543
Awardee: MEDAC · Tax ID 980369959
Awardee: FARMOZ - SOC TECNICO MEDICINAL SA · Tax ID 501505334
Awardee: NOVARTIS FARMA-PROD FARMACEUT · Tax ID 500063524
Awardee: BAYER PORTUGAL S A · Tax ID 500043256
Awardee: MEDA PHARMA S A · Tax ID 500082090

HOW MUCH AND WHEN

Values and timeline

Contract price: €140,041.13
Procedure base price: €205,000.00
Total effective price: Not reported on Portal BASE
Publication date: 21 March 2013
Award date: 26 November 2012
Signing date: 26 November 2012
Performance period: 8 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Not stated
CPV code: 33690000-3 - Medicamentos vários
Legal basis: Artigo 26.º, n.º 1, alínea e) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 18/2008)
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 596742

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts